Artwork

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Newest Viral Hepatitis Data From AASLD 2022

41:00
 
分享
 

Manage episode 349055647 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:

  • Hepatitis B
  • Prevention of HBV vertical transmission when HBIg is unavailable
  • Therapeutic vaccination for HBV cure
  • Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase
  • Hepatitis delta
  • HDV prevalence in ethnically diverse, urban, safety-net populations
  • Bulevirtide ± pegIFN-α2a for chronic HDV in the French cATU study
  • Bulevirtide monotherapy for patients with HDV and compensated cirrhosis in the HEP4Di study
  • HDV functional cure with lonafarnib-based therapy
  • Hepatitis C
  • Integrated community HCV service for PWUD: the ITTREAT study
  • Helios-3 study of treatment of people with HCV by specialists or nonspecialists
  • Risk of HCC after SVR in patients with HCV

Presenter:

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Follow along with the downloadable slideset at:
https://bit.ly/3FxIOwZ

Link to full program:
https://bit.ly/3Y1tD6f

  continue reading

378集单集

Artwork
icon分享
 
Manage episode 349055647 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:

  • Hepatitis B
  • Prevention of HBV vertical transmission when HBIg is unavailable
  • Therapeutic vaccination for HBV cure
  • Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase
  • Hepatitis delta
  • HDV prevalence in ethnically diverse, urban, safety-net populations
  • Bulevirtide ± pegIFN-α2a for chronic HDV in the French cATU study
  • Bulevirtide monotherapy for patients with HDV and compensated cirrhosis in the HEP4Di study
  • HDV functional cure with lonafarnib-based therapy
  • Hepatitis C
  • Integrated community HCV service for PWUD: the ITTREAT study
  • Helios-3 study of treatment of people with HCV by specialists or nonspecialists
  • Risk of HCC after SVR in patients with HCV

Presenter:

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Follow along with the downloadable slideset at:
https://bit.ly/3FxIOwZ

Link to full program:
https://bit.ly/3Y1tD6f

  continue reading

378集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南